Currency In USD
| Previous Close | 3.5 |
| Open | 3.51 |
| Day High | 3.68 |
| Day Low | 3.48 |
| 52-Week High | 12.5 |
| 52-Week Low | 2.07 |
| Volume | 77,762 |
| Average Volume | 78,227 |
| Market Cap | 10.05M |
| PE | -0.91 |
| EPS | -3.91 |
| Moving Average 50 Days | 3.46 |
| Moving Average 200 Days | 3.26 |
| Change | 0.04 |
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI
GlobeNewswire Inc.
Mar 05, 2026 1:20 PM GMT
Completion of enrollment marks a key milestone toward satisfying FDA post-approval requirementsDENVER, March 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)
GlobeNewswire Inc.
Feb 09, 2026 1:20 PM GMT
Strong survival data extending to 90 days Real-world experience shows results consistent with clinical trial data Favorable safety profile – no device-related adverse events DENVER, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporat
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference
GlobeNewswire Inc.
Jan 29, 2026 1:25 PM GMT
DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, annou